AIRLINK 73.70 Decreased By ▼ -0.30 (-0.41%)
BOP 4.99 Decreased By ▼ -0.03 (-0.6%)
CNERGY 4.48 Increased By ▲ 0.06 (1.36%)
DFML 39.44 Increased By ▲ 0.24 (0.61%)
DGKC 86.60 Increased By ▲ 0.51 (0.59%)
FCCL 21.71 Increased By ▲ 0.06 (0.28%)
FFBL 34.30 Increased By ▲ 0.29 (0.85%)
FFL 9.84 Decreased By ▼ -0.08 (-0.81%)
GGL 10.74 Increased By ▲ 0.18 (1.7%)
HBL 113.60 Decreased By ▼ -0.29 (-0.25%)
HUBC 135.99 Increased By ▲ 0.15 (0.11%)
HUMNL 12.10 Increased By ▲ 0.20 (1.68%)
KEL 4.75 Decreased By ▼ -0.09 (-1.86%)
KOSM 4.50 Decreased By ▼ -0.03 (-0.66%)
MLCF 38.53 Increased By ▲ 0.26 (0.68%)
OGDC 135.85 Increased By ▲ 1.00 (0.74%)
PAEL 26.19 Decreased By ▼ -0.16 (-0.61%)
PIAA 19.24 Decreased By ▼ -1.56 (-7.5%)
PIBTL 6.77 Increased By ▲ 0.09 (1.35%)
PPL 122.40 Decreased By ▼ -0.60 (-0.49%)
PRL 27.29 Increased By ▲ 0.60 (2.25%)
PTC 14.31 Decreased By ▼ -0.02 (-0.14%)
SEARL 58.49 Decreased By ▼ -0.63 (-1.07%)
SNGP 68.20 Decreased By ▼ -1.30 (-1.87%)
SSGC 10.30 Decreased By ▼ -0.03 (-0.29%)
TELE 8.52 Increased By ▲ 0.02 (0.24%)
TPLP 11.22 Decreased By ▼ -0.01 (-0.09%)
TRG 64.75 Decreased By ▼ -0.10 (-0.15%)
UNITY 26.27 Increased By ▲ 0.02 (0.08%)
WTL 1.33 Decreased By ▼ -0.01 (-0.75%)
BR100 7,876 Increased By 25.3 (0.32%)
BR30 25,362 Increased By 25.1 (0.1%)
KSE100 75,459 Increased By 251.9 (0.33%)
KSE30 24,240 Increased By 96.9 (0.4%)

GENEVA: The World Health Organization's vaccine advisers on Monday recommended people with weaker immune systems should be offered an additional dose of all authorised Covid-19 vaccines.

The UN health agency's Strategic Advisory Group of Experts on Immunisation (SAGE) also said over-60s who have been fully immunised with China's Sinovac and Sinopharm vaccine should be offered an additional third Covid-19 vaccine dose.

The experts stressed they were not recommending an additional so-called booster dose for the population at large.

Several Covid-19 vaccines have been given WHO approval for emergency use during the pandemic: Pfizer-BioNTech, Janssen, Moderna, Sinopharm, Sinovac and AstraZeneca.

AstraZeneca antibody drug important as preventative COVID-19 therapy

It is on the verge of deciding whether to give emergency use listing to India's Bharat Biotech jab.

SAGE held a four-day meeting last week to review the latest information and data on a range of vaccines for Covid-19 and other diseases.

"SAGE recommended that moderately and severely immunocompromised persons should be offered an additional dose of all WHO EUL (emergency use listing) Covid-19 vaccines as part of an extended primary series," the group said.

"These individuals are less likely to respond adequately to vaccination following a standard primary vaccine series and are at high risk of severe Covid-19 disease."

It also said that for people fully immunised with Sinovac and Sinopharm vaccines, an additional third dose of the same jab "should be offered to persons aged 60 and above".

A different vaccine "may also be considered based on vaccine supply and access considerations".

SAGE added that when implementing this recommendation, countries should initially aim at maximising two-dose coverage in that population, and thereafter administer the third dose, starting in the oldest age groups.

Comments

Comments are closed.